Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
The Oncologist|September 19, 2023
Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast CancerJuan Luis Gomez Marti, Azadeh Nasrazadani, Ying Ding, et al.Plos One|November 22, 2013
Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitorLindsay R Dresang, Anna Guastafierro, Reety Arora, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2010
Bayesian hierarchical changepoint methods in modeling the tumor growth profiles in xenograft experimentsLili Zhao, Meredith A Morgan, Leslie A Parsels, et al.International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with cautionMary Feng, James M Balter, Daniel Normolle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2003
Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancerJeffrey H Muler, Cornelius J McGinn, Daniel Normolle, et al.International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
Analysis of radiation-induced liver disease using the Lyman NTCP modelLaura A Dawson, Daniel Normolle, James M Balter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2009
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunctionYue Cao, Christina I Tsien, Pia C Sundgren, et al.Journal of Gastrointestinal Oncology|July 25, 2017
Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer-retrospective analysis of responseKhanh T Nguyen, Aparna Kalyan, H Scott Beasley, et al.Journal for Immunotherapy of Cancer|May 14, 2021
Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neckDan P Zandberg, Ashley V Menk, Maria Velez, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastomaKenneth F Koral, John P Huberty, Bill Frame, et al.Pageof 6